Circulating tumor cells in breast cancer: functional heterogeneity, pathogenetic and clinical aspects; Experimental Oncology; Vol. 39, № 1

Dades bibliogràfiques
Parent link:	Experimental Oncology Vol. 39, № 1.— 2016.— [P. 2-11]
Autor corporatiu:	Томский политехнический университет Институт кибернетики, ИК
Altres autors:	Cherdyntseva N. V. Nadezhda Viktorovna, Litviakov N. V. Nikolay Vladimirovich, Denisov E. V. Evgeny Vladimirovich, Gervas P. A. Polina Anatolevna, Cherdyntsev E. S. Evgeny Sergeevich
Sumari:	Title screen d that measuring changes in CTC numbers during treatment is useful for monitoring therapy response in breast cancer patients. Molecular and genetic analysis of CTC gives the opportunity to have timely information on emergence of resistant tumor clones and may shed light on the new targets for pathogenetic antitumor therapy.
Idioma:	anglès
Publicat:	2016
Matèries:	электронный ресурс труды учёных ТПУ опухоли нуклеиновые кислоты микросреда химиотерапия терапия
Accés en línia:	http://exp-oncology.com.ua/article/9310
Format:	Electrònic Capítol de llibre
KOHA link:	https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=655560

Internet